These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 23558074)
1. Correlation of S1P1 and ERp29 expression to progression, metastasis, and poor prognosis of gallbladder adenocarcinoma. Yuan LW; Liu DC; Yang ZL Hepatobiliary Pancreat Dis Int; 2013 Apr; 12(2):189-95. PubMed ID: 23558074 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of the Stem Cell Markers Epcam and CD133 Expression Of Gallbladder Adenocarcinoma. Jiang S; Pei L; Yang ZL; Liu G Hepatogastroenterology; 2014 May; 61(131):574-9. PubMed ID: 26176038 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of MTA1 and loss of KAI-1 and KiSS-1 expressions are associated with invasion, metastasis, and poor-prognosis of gallbladder adenocarcinoma. Wang W; Yang ZL; Liu JQ; Yang LP; Yang XJ; Fu X Tumori; 2014; 100(6):667-74. PubMed ID: 25688501 [TBL] [Abstract][Full Text] [Related]
4. Expression of MK-1 and RegIV and its clinicopathological significances in the benign and malignant lesions of gallbladder. Yang L; Lan S; Liu J; Yang Z Diagn Pathol; 2011 Oct; 6():100. PubMed ID: 22018336 [TBL] [Abstract][Full Text] [Related]
5. Association of BDNF and BMPR1A with clinicopathologic parameters in benign and malignant gallbladder lesions. Xiong L; Deng X; Wen Y; Yang Z; Miao X World J Surg Oncol; 2013 Mar; 11():80. PubMed ID: 23531103 [TBL] [Abstract][Full Text] [Related]
6. Expression of ezrin, HGF and c-met and its clinicopathological significance in the benign and malignant lesions of the gallbladder. Yang L; Guo T; Jiang S; Yang Z Hepatogastroenterology; 2012 Sep; 59(118):1769-75. PubMed ID: 22172411 [TBL] [Abstract][Full Text] [Related]
7. Identification of PEG10 and TSG101 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Pathol Oncol Res; 2011 Dec; 17(4):859-66. PubMed ID: 21455631 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder. Liu DC; Yang ZL Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106 [TBL] [Abstract][Full Text] [Related]
9. Up-regulation of galectin-3 and Sambucus nigra agglutinin binding site is associated with invasion, metastasis and poor-progression of the gallbladder adenocarcinoma. Yang LP; Jiang S; Liu JQ; Miao XY; Yang ZL Hepatogastroenterology; 2012 Oct; 59(119):2089-94. PubMed ID: 22497866 [TBL] [Abstract][Full Text] [Related]
10. Identification of musashi-1 and ALDH1 as carcinogenesis, progression, and poor-prognosis related biomarkers for gallbladder adenocarcinoma. Liu DC; Yang ZL; Jiang S Cancer Biomark; 2010-2011; 8(3):113-21. PubMed ID: 22012766 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of PUMA, c-Myb and p53 expression in the benign and malignant lesions of gallbladder and their clinicopathological significances. Shu GS; Lv F; Yang ZL; Miao XY Int J Clin Oncol; 2013 Aug; 18(4):641-50. PubMed ID: 22714709 [TBL] [Abstract][Full Text] [Related]
12. Expression of VHL and HIF-1α and Their Clinicopathologic Significance in Benign and Malignant Lesions of the Gallbladder. Yang Z; Yang Z; Xiong L; Huang S; Liu J; Yang L; Miao X Appl Immunohistochem Mol Morphol; 2011 Dec; 19(6):534-9. PubMed ID: 21415706 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of DNA fragmentation factor 45 and thyroid transcription factor 1 expression in benign and malignant lesions of the gallbladder. Yuan Y; Yang ZL; Zou Q; Cao LF; Tan XG; Jiang S; Miao XY Pol J Pathol; 2013 Apr; 64(1):44-51. PubMed ID: 23625600 [TBL] [Abstract][Full Text] [Related]
14. Expressive levels of MUC1 and MUC5AC and their clinicopathologic significances in the benign and malignant lesions of gallbladder. Xiong L; Yang Z; Yang L; Liu J; Miao X J Surg Oncol; 2012 Jan; 105(1):97-103. PubMed ID: 21815153 [TBL] [Abstract][Full Text] [Related]
15. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas. Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611 [TBL] [Abstract][Full Text] [Related]
16. N-cadherin and P-cadherin are biomarkers for invasion, metastasis, and poor prognosis of gallbladder carcinomas. Yi S; Yang ZL; Miao X; Zou Q; Li J; Liang L; Zeng G; Chen S Pathol Res Pract; 2014 Jun; 210(6):363-8. PubMed ID: 24636838 [TBL] [Abstract][Full Text] [Related]
17. [Expression of ephrin-A7 and metadherin and its clinicopathological significances in the benign and malignant lesions of gallbladder]. Liu DC; Yang ZL Zhonghua Wai Ke Za Zhi; 2011 Mar; 49(3):250-5. PubMed ID: 21609571 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of nuclear hepatoma-derived growth factor expression in gallbladder cancer. Tao F; Ye MF; Sun AJ; Lv JQ; Xu GG; Jing YM; Wang W World J Gastroenterol; 2014 Jul; 20(28):9564-9. PubMed ID: 25071353 [TBL] [Abstract][Full Text] [Related]
19. Comparative study of ROR2 and WNT5a expression in squamous/adenosquamous carcinoma and adenocarcinoma of the gallbladder. Wu ZC; Xiong L; Wang LX; Miao XY; Liu ZR; Li DQ; Zou Q; Liu KJ; Zhao H; Yang ZL World J Gastroenterol; 2017 Apr; 23(14):2601-2612. PubMed ID: 28465645 [TBL] [Abstract][Full Text] [Related]
20. Expression levels of HMGA2 and CD9 and its clinicopathological significances in the benign and malignant lesions of the gallbladder. Zou Q; Xiong L; Yang Z; Lv F; Yang L; Miao X World J Surg Oncol; 2012 May; 10():92. PubMed ID: 22613496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]